MEI Pharma Receives Over $100 Million in Commitments to Launch Litecoin Treasury Strategy

This article is machine translated
Show original

According to ChainCatcher, information from Titan Partners Group and the crypto investment company GSR indicates that the American pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing a dedicated Litecoin treasury strategy. Currently, over $100 million in funds have been committed to this project.

It is worth noting that Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors. Additionally, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy is highly aligned with the foundation's core mission of promoting global Litecoin adoption.

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
2
Add to Favorites
Comments